The thiazolidinedione, troglitazone, does not initiate ventricular cardiomyocyte hypertrophy in vitro but may sensitise cardiomyocytes to the hypertrophic effects of serum growth factors

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)1
Number of pages1
JournalJournal of Molecular and Cellular Cardiology
Volume32
Publication statusPublished - 01 May 1999

Cite this